Pharmacoengineering
Pharmacoengineers apply life sciences, chemistry and physics with theoretical and quantitative methods from engineering, mathematics and computer science to solve problems in medicine and drug therapies. Our program, which partners with the Eshelman School of Pharmacy under their Division of Pharmacoengineering and Molecular Pharmaceutics, prepares students to work at the interface of engineering and pharmaceutical sciences to develop safer and more effective medicine and medical technologies.
Pharmacoengineering Laboratories
Benhabbour Research Laboratory
Dr. Benhabbour’s laboratory is in the UNC-Eshelman School of Pharmacy at the Division of Molecular Pharmaceutics and is part of the Center in Nanotechnology and Drug Delivery (CNDD). Our lab collaborates with experts in the fields of oncology and HIV research, both on the basic research and clinical sides. Our goal is to develop new devices and technologies that can be translated from the bench side to the bedside and impact human health.
Molecular Pharmacoengineering Lab
The Molecular Pharmacoengineering Lab focuses on exploiting cutting-edge chemical, biomaterial and nanomedicine technologies to understand physiological responses during disease and regeneration and fulfill critical unmet needs in the clinic. Our group studies controlled drug delivery, bio-inspired materials and nanomedicine, with a focus on cancer chemotherapy and immunotherapy.
The Gomez Lab
The Gomez Lab is primarily a bioinformatics and computational modeling group. Its research focuses on the study of biological processes from an integrated, or systems viewpoint – commonly referred to as Systems Biology. The group is particularly interested in better understanding the “wiring” of biological systems and the discovery of underlying principles in biological organization.
Zaharoff Laboratory
The Zaharoff Lab focuses on the development of innovative, translatable vaccine and immunotherapy delivery platforms that will have high clinical impact in an immediate timeframe. Our multidisciplinary research program utilizes the engineering design process to develop novel biomaterials-based strategies for localized immunotherapy delivery.